Detalhe da pesquisa
1.
Molecular determinants of clinical outcomes of pembrolizumab in recurrent ovarian cancer: Exploratory analysis of KEYNOTE-100.
Gynecol Oncol
; 178: 119-129, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37862791
2.
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses.
Mod Pathol
; 34(1): 194-206, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32724153
3.
A Keratin 7 and E-Cadherin Signature Is Highly Predictive of Tubo-Ovarian High-Grade Serous Carcinoma Prognosis.
Int J Mol Sci
; 22(10)2021 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34070214
4.
Lifetime recreational moderate-to-vigorous physical activity and ovarian cancer risk: A case-control study.
Int J Cancer
; 146(7): 1800-1809, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31199510
5.
Distinct Histologic, Immunohistochemical and Clinical Features Associated With Serous Endometrial Intraepithelial Carcinoma Involving Polyps.
Int J Gynecol Pathol
; 39(2): 128-135, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30789501
6.
Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers.
BMC Cancer
; 18(1): 347, 2018 03 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29587661
7.
Hormonal and reproductive factors and the risk of ovarian cancer.
Cancer Causes Control
; 28(5): 393-403, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28102526
8.
Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2.
Gynecol Oncol
; 143(1): 27-34, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27546885
9.
Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial.
Lancet Oncol
; 15(8): 799-808, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24950985
10.
Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix.
Int J Gynecol Cancer
; 24(9 Suppl 3): S102-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25341572
11.
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian small cell cancers.
Int J Gynecol Cancer
; 24(9 Suppl 3): S30-4, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25341577
12.
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian sex cord stromal tumors.
Int J Gynecol Cancer
; 24(9 Suppl 3): S42-7, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25341579
13.
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors).
Int J Gynecol Cancer
; 24(9 Suppl 3): S5-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25341581
14.
Gynecologic Cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterus.
Int J Gynecol Cancer
; 24(9 Suppl 3): S73-7, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25341584
15.
Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinoma.
Int J Gynecol Cancer
; 24(9 Suppl 3): S83-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25341586
16.
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomas.
Int J Gynecol Cancer
; 24(9 Suppl 3): S9-13, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25341587
17.
Contribution of the PALB2 c.2323C>T [p.Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent.
BMC Med Genet
; 14: 5, 2013 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-23302520
18.
Inhibition of nicotinamide dinucleotide salvage pathway counters acquired and intrinsic poly(ADP-ribose) polymerase inhibitor resistance in high-grade serous ovarian cancer.
Sci Rep
; 13(1): 3334, 2023 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849518
19.
Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer.
BMC Cancer
; 12: 379, 2012 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-22931248
20.
Impact of hemochromatosis gene (HFE) mutations on epithelial ovarian cancer risk and prognosis.
Int J Cancer
; 128(10): 2326-34, 2011 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20669231